Evidence map›Paper›PMID 37635973›Full record

ArticleFrontiers in endocrinology2023

Sex non-specific growth charts and potential clinical implications in the care of transgender youth.

Eric Morris Bomberg, Bradley Scott Miller, Oppong Yaw Addo, Alan David Rogol, Mutaz M Jaber, Kyriakie Sarafoglou

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Clinical pharmacology in adolescent transgender medicine.British journal of clinical pharmacology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Eric Morris BombergDivision of Endocrinology, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN, United States.
Bradley Scott MillerDivision of Endocrinology, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN, United States.
Oppong Yaw AddoDepartment of Global Health, Rollins School of Emory University, Atlanta, GA, United States.
Alan David RogolDivision of Diabetes and Endocrinology, Department of Pediatrics, University of Virginia, Charlottesville, VA, United States.
Mutaz M JaberDepartment of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, MN, United States.
Kyriakie SarafoglouDivision of Endocrinology, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN, United States.
University of Minnesota · USUniversity of Minnesota Medical Center · USEmory University · USUniversity of Virginia · US

Funding

Precision Medicine Approaches to Obesity Pharmacotherapy in Youth with Severe ObesityK23DK125668 · NIDDK · UNIVERSITY OF MINNESOTA · PI BOMBERG, ERIC MORRIS · 2020 to 2024
$1.0M
NIDDK NIH HHS K23 DK125668
6 · The paper itself

Abstract

Introduction: The Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) created separate growth charts for girls and boys because growth patterns and rates differ between sexes. However, scenarios exist in which this dichotomizing "girls versus boys" approach may not be ideal, including the care of non-binary youth or transgender youth undergoing transitions consistent with their gender identity. There is therefore a need for growth charts that age smooth differences in pubertal timing between sexes to determine how youth are growing as "children" versus "girls or boys" (e.g., age- and sex-neutral, compared to age- and sex-specific, growth charts). Methods: Employing similar statistical techniques and datasets used to create the CDC 2000 growth charts, we developed age-adjusted, sex non-specific growth charts for height, weight, and body mass index (BMI), and z-score calculators for these parameters. Specifically, these were created using anthropometric data from five US cross-sectional studies including National Health Examination Surveys II-III and National Health and Nutrition Examination Surveys I-III. To illustrate contemporary clinical practice, we overlaid our charts on CDC 2000 girls and boys growth charts. Results: 39,119 youth 2-20 years old (49.5% female; 66.7% non-Hispanic White; 21.7% non-Hispanic Black) were included in the development of our growth charts, reference ranges, and z-score calculators. Respective curves were largely superimposable through around 10 years of age after which, coinciding with pubertal onset timing, differences became more apparent. Discussion: We conclude that age-adjusted, sex non-specific growth charts may be used in clinical situations such as transgender youth in which standard "girls versus boys" growth charts are not ideal. Until longitudinal auxological data are available in these populations, our growth charts may help to assess a transgender youth's growth trajectory and weight classification, and expectations surrounding these.

Indexed as

Gender IdentityTransgender PersonsAdolescentAdultChildChild, PreschoolCross-Sectional StudiesFemaleGrowth ChartsHumansMaleSexual BehaviorUnited StatesYoung Adultbody mass indexgrowthgrowth chartsnutrition surveyspediatric obesitytransgender

Identifiers

PMID37635973
PMCPMC10455911
OpenAlexW4385754398

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.